Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis

• Status: Unknown status
• Trial end date: 2007-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is being done to see in B12 applied to the skin will improve the symptoms of eczema in children compared to a placebo creme

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Spartanburg Regional Family Medicine

Criteria

Inclusion Criteria:

• children presenting to the Center for Family Medicine or Regional Pediatrics between the ages of 6 months and 18 years old with atopic dermatitis

Exclusion Criteria:

• unwillingness of parent to consent to study protocol, pregnancy or lactation, eczema with superinfection present, known history of allergy to Vitamin B12 or components of the base cream, topical treatment with corticosteroids in the 4 weeks prior to enrollment